Amundi Intermédiation Selects FlexTrade for Multi-Asset Execution Management
26.7.2023 11:25:00 EEST | Business Wire | Press release
FlexTrade Systems, a global leader in multi-asset execution and order management systems, today announced that European execution platform leader, Amundi Intermédiation, has selected FlexTRADER EMS to consolidate all asset classes traded onto a single, scalable, multi-asset EMS platform. Amundi Intermédiation, the execution business subsidiary of Amundi Asset Management, additionally acts as an outsourced execution provider for Asset Managers, Private Banking, and Insurance companies, which globally executes approximately €5 trillion across all asset classes for around 60 clients.
Consolidation of front office technology and automation initiatives are currently in sharp focus for global buy-side institutions to streamline and optimize execution workflows in equities and extend the efficiencies to other asset classes, including fixed income.
FlexTrade’s FlexTRADER EMS solution will be deployed as Amundi Intermédiation’s global, centralized EMS platform to deliver cross-asset trading capabilities to over 60 dealers within its international investment hubs across trading desks in Paris, Dublin, Singapore and Tokyo. The move is designed to deliver dealers a common, robust set of tools and processes to handle cross-asset trading and execution efficiently.
Further, by deploying FlexTRADER EMS, Amundi Intermédiation’s dealing teams will benefit from sophisticated automation tools to streamline order and workflow management through FlexAlgowheel across all asset classes, enabling the firm to scale up its trading volumes alongside business growth efficiently.
With the move to deploy FlexTRADER EMS, Amundi Intermédiation will use FlexTrade’s unique fixed-income capabilities to bring more automation and electronification to their bond executing operations. Amundi Intermédiation will replace existing multi-platform processes through a single fixed-income EMS and deliver an aggregated view of the market and bilateral connectivity to liquidity providers. Further, using FlexTrade’s Fixed Income Smart Order Router (FISOR), its bond dealers can enrich their automation capabilities using consolidated pre-trade data to ensure best execution.
The project will be delivered in multiple phases, with equities and derivatives now live and in production across Amundi Intermédiation’s global trading desks. Fixed income will be deployed by the end of the year 2023.
Andy Mahoney, Managing Director, EMEA at FlexTrade, noted: “We are delighted to welcome Europe’s largest execution platform to FlexTrade. Proactively choosing to consolidate onto a single platform is a strategic vision to ensure Amundi Intermédiation’s execution operations have the core trading technology platform its businesses need to deliver the best outcomes to its clients. Notably, Amundi Intermédiation will also leverage our fixed-income capabilities, further validating the growing trend in the market to electronify bond trading activities.”
About FlexTrade Systems:
FlexTrade Systems is a global leader in high performance multi-asset execution management and order management systems for equities, fixed income, foreign exchange, futures, and options. A pioneer in the field, FlexTrade is internationally recognized for introducing FlexTRADER®, the world’s first broker-neutral, execution management trading system, which allows clients to completely control and customize their execution workflows through a comprehensive ability to search/access liquidity while maintaining the confidentiality of their trading strategies.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230726633077/en/
Contact information
Iain Smith
Iain.Smith@FlexTrade.com
o: +44 (0)20 3757 9311
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
